Literature DB >> 30569818

De novo generation of specific human IgGs by in vitro immunization using autologous proteins containing immunogenic p-nitrophenylalanine.

Yue Tong1, Xu Fang1, Hong Tian1, Shengwei Zhong1, Liang Jin1, Xiangdong Gao1, Wenbing Yao1.   

Abstract

In vitro immunization can to used to produce monoclonal antibodies(mAbs), but this technology is limited by poor reproducibility and the requirement of pre-immunized lymphocytes. To improve this approach, we recently developed a method for rapid generation of antigen-specific B cells. Here, we report the application of this system to the production of human IgGs against tumor necrosis factor (TNF). We expressed mutant proteins with site-specific incorporated p-nitrophenylalanine (pNO2Phe), which stimulated an in vitro immune response in human immune cells. After constructing an antigen-specific antibody library from in vitro immunized B cells identified by fluorescence-activated cell sorting, we demonstrated that many point mutation events of the variable region occurred in our step-by-step co-cultivation system for affinity maturation in vitro. To mimic the class switching, we panned for high-affinity antigen-binding fragments by the phage display method, assembled them and identified hTNF-neutralizing human IgGs. This approach may provide a general method for raising high-affinity monoclonal antibodies against self-proteins. Furthermore, it supports mechanistic understanding in breaking human self-tolerance with pNO2Phe.

Entities:  

Keywords:  IgGs; In vitro immunization; full human monoclonal antibodies; immunological tolerance; p-nitrophenylalanine

Mesh:

Substances:

Year:  2018        PMID: 30569818      PMCID: PMC6380431          DOI: 10.1080/19420862.2018.1537580

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  28 in total

1.  Combination of phage and Gram-positive bacterial display of human antibody repertoires enables isolation of functional high affinity binders.

Authors:  Francis Jingxin Hu; Anna-Luisa Volk; Helena Persson; Anna Säll; Carl Borrebaeck; Mathias Uhlen; Johan Rockberg
Journal:  N Biotechnol       Date:  2017-08-01       Impact factor: 5.079

2.  Mimicking the humoral immune response in vitro results in antigen-specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1-neutralizing IgG monoclonal antibodies from naive donors.

Authors:  L T Chin; A C Malmborg; K Kristensson; J Hinkula; B Wahren; C A Borrebaeck
Journal:  Eur J Immunol       Date:  1995-03       Impact factor: 5.532

Review 3.  Characteristics of human antibody repertoires following active immune responses in vivo.

Authors:  M Ohlin; C A Borrebaeck
Journal:  Mol Immunol       Date:  1996 May-Jun       Impact factor: 4.407

4.  A method for inducing antigen-specific IgG production by in vitro immunization.

Authors:  Mieko Kato; Huimin Yan; Noriko M Tsuji; Tomoki Chiba; Yoshiro Hanyu
Journal:  J Immunol Methods       Date:  2012-09-10       Impact factor: 2.303

Review 5.  Human antibodies as next generation therapeutics.

Authors:  M A van Dijk; J G van de Winkel
Journal:  Curr Opin Chem Biol       Date:  2001-08       Impact factor: 8.822

Review 6.  Pathophysiology of T follicular helper cells in humans and mice.

Authors:  Hideki Ueno; Jacques Banchereau; Carola G Vinuesa
Journal:  Nat Immunol       Date:  2015-02       Impact factor: 25.606

7.  Mutational analysis of human tumor necrosis factor-alpha.

Authors:  Hang-Cheol Shin; Kwang-Hwi Cho
Journal:  Biotechnol Lett       Date:  2005-01       Impact factor: 2.461

8.  Immunochemical termination of self-tolerance.

Authors:  Jan Grünewald; Meng-Lin Tsao; Roshan Perera; Liqun Dong; Frank Niessen; Ben G Wen; Diane M Kubitz; Vaughn V Smider; Wolfram Ruf; Marc Nasoff; Richard A Lerner; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

9.  Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids.

Authors:  Jan Grünewald; Grady S Hunt; Liqun Dong; Frank Niessen; Ben G Wen; Meng-Lin Tsao; Roshan Perera; Mingchao Kang; Bryan A Laffitte; Sassan Azarian; Wolfram Ruf; Marc Nasoff; Richard A Lerner; Peter G Schultz; Vaughn V Smider
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

10.  Antibodies to watch in 2018.

Authors:  Hélène Kaplon; Janice M Reichert
Journal:  MAbs       Date:  2018-01-16       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.